Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared a post on LinkedIn about a recent article by Nathan W. Watson et al, published in Stroke, adding:
“Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-analysis
Antiphospholipid antibodies (aPL) are associated with an increased risk of thrombosis.
However, individual studies have reported conflicting findings regarding the prevalence of aPL in patients with ischemic stroke and their association with initial or recurrent events.
Seropositivity for any aPL was observed in nearly 1 in 5 patients with ischemic stroke and was associated with a higher likelihood of ischemic stroke at clinical presentation.”
Title: Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-Analysis
Authors: Nathan W. Watson, Syed Bukhari, Sina Rashedi, Mariana Pfeferman, Francisco Ujueta, Bassil Bacare, Brittany N. Weber, Mehrdad Zarghami, Yogendra Kanthi, Eric A. Secemsky, Jean M. Connors, Geoffrey D. Barnes, Sacha Uljon, Samuel Z. Goldhaber, Jeffrey I. Weitz, Karen H. Costenbader, Harlan M. Krumholz, Gregory Piazza, Mary Cushman, Christopher D. Anderson, Mitchell S. V. Elkind, Behnood Bikdeli
Other posts featuring Leonardo Roever on Hemostasis Today.
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal
-
Sep 3, 2026, 00:33Hannah Isles: Interesting Link between Aging, Serotonin, Platelets and COVID-19 Severity
-
Sep 3, 2026, 00:22Danny Hsu: Paradigm Shift in PE Management? – Unpacking the PRAGUE-26 Trial
-
Sep 3, 2026, 00:03Jochebed Adwoa Sutherland: First Reported Case of Breast Mondor’s Disease in a Patient Living with Sickle Cell
-
Sep 2, 2026, 23:50Shashank Joshi: Individualized vs. Standard BP Control Shows Similar 90-Day Outcomes
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia